CLLS — CELLECTIS S A
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About CELLECTIS S A (CLLS)
CELLECTIS S A (CLLS) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $632,583. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in CLLS
How many top investors track CLLS
Only 2 tracked investors report this position.
CLLS Ownership Composition
How CELLECTIS S A is held across tracked investor types, based on reported 13F positions.
- Other51.5%
- Hedge Funds48.5%
Tracked investors reporting CLLS
- Ken GriffinMar 31, 2026Citadel AdvisorsShares44.3KValue$140.5K% Portfolio0.00%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares27.3KValue$132.2K% Portfolio0.00%
Recent activity
- New$132.2KFeb 17, 2026
Frequently asked questions
- How many institutional investors hold CLLS?
- 2 tracked institutional investors disclosed a position in CLLS (CELLECTIS S A) in their most recent 13F filing.
- Who is the largest institutional holder of CLLS?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in CLLS, valued at $632,583.
- Did institutional ownership of CLLS increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited CLLS.
- Where does this CLLS ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.